Table 7 Clinical-pathological characteristics of 1212 patients
Variables | Â | No. | % |
|---|---|---|---|
Menstrual status | Premenopausal | 368 | 30.4 |
| Â | Postmenopausal | 811 | 66.9 |
| Â | Unknown | 33 | 2.7 |
LN status | Negative | 645 | 53.2 |
| Â | Positive | 563 | 46.5 |
| Â | Unknown | 4 | 0.3 |
Histological diagnosis | Ductal | 1149 | 94.8 |
| Â | Lobular | 48 | 4 |
| Â | Other | 15 | 1.2 |
Systemic therapy | No adjuvant systemic therapy | 484 | 39.9 |
| Â | Tamoxifen, no chemotherapy | 398 | 32.8 |
| Â | Chemotherapy, no Tamoxifen | 228 | 18.8 |
| Â | Chemotherapy and Tamoxifen | 100 | 8.3 |
| Â | Ovarian ablation or hormono-therapy other than Tamoxifen, no chemotherapy | 1 | 0.1 |
| Â | Ovarian ablation or hormono-therapy other than Tamoxifen, and chemotherapy | 1 | 0.1 |